快讯摘要 强生公司近日宣布,将以每股335.00美元,总计约131亿美元收购心血管设备制造商Shockwave Medical,此举旨在借助Shockwave的血管内碎石技术,加强其在医疗科技领域的影响力。强生计划通过现金和债务筹集资金,预计交易将于2024年中完成。尽管收购初期可能导致公司2024年和2025年的每股收益分别减少约0.10美元和约0.17美元,...
Johnson & Johnson MedTech‘sShockwave Medicaltoday announced the U.S. launch of its Javelin peripheral intravascular lithotripsy (IVL) catheter. The Javelin aims to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease (PAD). Shockwave said its novel, non-bal...
Shockwave Medical Has Not Yet Made a Top Formation SWAV has more to go on the upside. Breaking News Investing News, Analysis, and Tips Feb 21, 2025 10:14 AM EST Goldman Sachs analyst revisits Rivian stock price target after Q4 earnings ...